There has been a simmering debate since the start of 2021 as to whether China might overtake the US as the engine of world growth...

No sooner had this column raised the question as to whether its status as the single-best performer within the FTSE 350 over the last...

For a time, bitcoin became just too big to ignore, with the cryptocurrency reaching all-time highs above $64,000 in April. When the price of an...

The muted reaction to a positive update from housebuilder Vistry (VTY) on 17 May suggests the market has already priced in the current...

A big story of the first four-and-a-bit months of 2021 has been a recovery for UK assets with the domestic-facing FTSE 250 index reaching all-time highs...

COCA-COLA HBC (CCH) 25.09

Gain to date: 7.3%

Original entry point: Buy at £23.38, 17 December 2020

OUR ‘buy’ call on...

Diageo (DGE) £33.65

Gain to date: 14.3%

Original entry point: Buy at £29.45, 23 December 2020

OUR positive call on alcoholic...

UDG Healthcare (UDG) £10.23

Gain to date: 47.4%

Original entry point: Buy at 694p, 16 July 2020

It seems that others...

Specialty biotech company Shield Therapeutics (STX:AIM) is at an exciting point in its development and is worth buying before the market switches on...

Coming just six weeks after shares in food takeaway platform Deliveroo (ROO) dropped more than 30% on its first day as a public...